<DOC>
	<DOCNO>NCT01746381</DOCNO>
	<brief_summary>Home non-invasive ventilation ( NIV ) standard-of-care initial therapy patient ALS worsen symptom deteriorate respiratory function , recommend American Academy Neurology ( AAN ) practice parameter ALS . This study compare current standard BiST mode ventilation new iVAPS mode . The main study hypothesis iVAPS mode , initiate single daytime trial , result reduction number respiratory therapist intervention change ventilator setting compare standard BiST mode . This assessed period one year . In addition study test whether iVAPS mode superior BiST mode respect : comfort ease use ; improvement nighttime daytime symptom hypoventilation ; compliance ( hour use per day ) ; physiologic parameter ( daytime overnight oxygen saturation transcutaneous CO2 level ) .</brief_summary>
	<brief_title>Non-invasive Ventilation Amyotrophic Lateral Sclerosis ( ALS ) Using iVAPS Mode</brief_title>
	<detailed_description>Amyotrophic lateral sclerosis ( ALS ) neurodegenerative disorder incurable , progressive , manifested muscle weakness wasting , cause degeneration motor neurones . The limited data available suggest incidence ALS Canada approximately 2 per 100,000 person . The disease characterize progressive weakness respiratory muscle , lead respiratory insufficiency often cause death patient ALS . Home non-invasive ventilation ( NIV ) standard-of-care initial therapy patient ALS worsen symptom deteriorate respiratory function , recommend American Academy Neurology ( AAN ) practice parameter ALS . The symptomatic survival benefit offer NIV patient ALS make optimization ventilation priority term physiological variable also symptoms improve comfort , consequently , compliance . The Intelligent Volume-Assured Pressure Support ( iVAPS ) ventilator mode Stellar 150 ventilator ( Resmed ) use algorithm target alveolar ventilation . It learn mode determine initial optimal setting commence ventilation , adaptive mode , constantly monitor patient 's spontaneous ventilation adjusts level pressure support maintain target alveolar ventilation . The aim study determine feasibility long-term non-invasive home ventilation ALS patient use Stellar 150 IVAPS mode , initiate single daytime trial , assess number respiratory therapist intervention subsequently require well several patient-centered outcome . The study conduct among patient ALS refer National Program Home Ventilatory Assistance ( NPHVA ) Montreal Chest Institute . The province-wide program provide home ventilation service patient variety neuromuscular disorder . Referred patient randomize receive traditional Bilevel ventilation ST mode ( BiST ) iVAPS follow period one year . Respiratory therapist intervention ( beyond schedule visit ) change ventilator setting base patient complaint aim optimize patient comfort ventilator use . In addition , symptom questionnaire administer regularly , overnight oxymetry transcutaneous capnography ( 6 12 month ) perform . Compliance data assess regularly ventilator memory downloads schedule respiratory therapist home visit ( 1 week , 1 , 6 12 month ) .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Patients refer National Program Home Ventilatory Assistance ( NPHVA ) Montreal Chest Institute home ventilation . Patients meet eligibility criterion home ventilation per Quebec Health Ministry reference frame document home ventilation ( http : //publications.msss.gouv.qc.ca/acrobat/f/documentation/2011/1193601W.pdf ) . Adequate knowledge English French complete study questionnaire . The lack eligibility home ventilation , per document mention Active cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>amyotrophic lateral sclerosis</keyword>
	<keyword>non-invasive ventilation</keyword>
	<keyword>home ventilation</keyword>
	<keyword>IVAPS</keyword>
	<keyword>neuromuscular disease</keyword>
</DOC>